Skip to main navigation
  • About Stoke
    • Overview
    • Leadership
    • Founders
    • Corporate Responsibility
  • Scientific Platform
    • Overview
    • Tango
    • Publications
  • Disease Areas
    • Overview
    • Dravet Syndrome
    • ADOA
    • Rett Syndrome
    • SYNGAP1
    • Pipeline
  • Patients & Families
    • Overview
    • Clinical Studies
    • Expanded Access Policy
    • Educational Resources
  • Careers & Culture
    • Overview
    • Job Opportunities
    • Diversity, Inclusion & Belonging
  • Investors & News
    • Overview
    • Media Room
    • Press Releases
    • Events & Presentations
    • Financials & SEC Filings
    • Stock Information
    • Analyst Coverage
    • Governance
Stoke Therapeutics
  • Contact Us
  • LinkedIn
  • Twitter
  • About Stoke
    • Overview
    • Leadership
    • Founders
    • Corporate Responsibility
  • Scientific Platform
    • Overview
    • Tango
    • Publications
  • Disease Areas
    • Overview
    • Dravet Syndrome
    • ADOA
    • Rett Syndrome
    • SYNGAP1
    • Pipeline
  • Patients & Families
    • Overview
    • Clinical Studies
    • Expanded Access Policy
    • Educational Resources
  • Careers & Culture
    • Overview
    • Job Opportunities
    • Diversity, Inclusion & Belonging
  • Investors & News
    • Overview
    • Media Room
    • Press Releases
    • Events & Presentations
    • Financials & SEC Filings
    • Stock Information
    • Analyst Coverage
    • Governance
  • Home
  • Investors & News
  • Financials & SEC Filings
  • SEC Filing Details

SEC Filing Details

Document Details

Form
4
Filing Date
June 15, 2023
Document Date
June 13, 2023
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
Form 3,4,5
Company
Stoke Therapeutics
Issuer
Stoke Therapeutics, Inc.
Filer
Harrison Seth Loring

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS
Print Page
Email Alerts
Contact IR
Investor FAQs
  • About Stoke
  • Scientific Platform
  • Disease Areas
  • Patients & Families
  • Careers & Culture
  • Investors & News
  • Contact Us
Stoke Logo

© 2023 Stoke Therapeutics, all rights reserved.

  • Privacy Policy
  • Terms of Use
  • Site Map
  • LinkedIn
  • Twitter